Small-Caps

GW GAINS FROM FDA'S STAND ON CANNABIS USE

*GW Pharmaceuticals, which is developing medicines derived from
cannabis, was given a lift as the US Food and Drug Administration
confirmed it did not endorse the smoking of the drug for medical
purposes. Evolution Securities said this was good news for GW as it
may make its product a "politically expedient option". GW shares
gained 10.1 per cent to 98p.

*Gondola Holdings, owner of Pizza Express, fell 1.8 per cent to
3371/2p on fears that a large chunk of stock could hit the market
next month. From May 9 two pre-flotation backers, TDR Capital and
Capricorn Ventures, will be free to sell their holding of 51 per cent.